Trial intelligence / Profile preview

Early vs. Standard Postpartum IUD Placement

NCT01594476Phase 4Terminated

Sponsor
Oregon Health & Science University
Start
Mar 2012
Primary completion
Apr 2014
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

A Phase 4 trial of avatrombopag, TCu 380A, sponsored by Oregon Health & Science University. Started Mar 2012; status: terminated.

02

Drugs

avatrombopagTCu 380A

Beyond the preview

Go deeper on NCT01594476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01594476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call